Find clinical trials for Lymphoma in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near San Francisco, CA, USA:
This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...
Phase 2
Palo Alto, California, United States and 7 other locations
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Berkeley, California, United States and 125 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
San Francisco, California, United States and 59 other locations
Lenalidomide has been shown to have single agent activity in indolent Non-Hodgkin's Lymphoma. It is approved for the treatment of multiple m...
Phase 2
Santa Rosa, California, United States and 1 other location
017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....
Phase 1
San Francisco, California, United States and 13 other locations
This is a First-in-Human Phase I trial of ATG-101 in Patients with Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas....
Phase 1
San Francisco, California, United States and 7 other locations
in patients with relapsed central nervous system (CNS) lymphoma. This is the first study to examine a naked anti-CD19 monoclonal antibody in...
Phase 1, Phase 2
San Francisco, California, United States
is evaluating a novel drug called CUDC-907 as a possible treatment for resistant (refractory) pediatric solid tumors (including neuroblastoma), lymphoma...
Phase 1
San Francisco, California, United States and 3 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
San Francisco, California, United States and 93 other locations
A Phase 1/2 Study of bbT369, a dual targeting CAR T cell drug product with a gene edit, in Relapsed and/or Refractory B cell Non-Hodgkin's Lymphoma...
Phase 1, Phase 2
Stanford, California, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal